Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 40, 2014 - Issue 10
Submit an article Journal homepage
220
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of systemic exposure of nanoparticle suspensions subcutaneously administered to mice regarding stabilization, volume, location, concentration and size

Kalle SigfridssonDivision of Pharmaceutical Development, AstraZeneca R&D Mölndal MölndalSweden;Department of Chemical and Biological Engineering, Chalmers University of Technology GöteborgSwedenCorrespondence[email protected]
&
Malin PalmerDivision of Bioscience, CVGI, AstraZeneca R&D Mölndal MölndalSweden
Pages 1318-1324 | Received 25 Feb 2013, Accepted 13 Jun 2013, Published online: 23 Jul 2013

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jan Sobczyński, Gro Smistad, Anne Bee Hegge & Solveig Kristensen. (2015) Molecular interactions and solubilization of structurally related meso-porphyrin photosensitizers by amphiphilic block copolymers (Pluronics). Drug Development and Industrial Pharmacy 41:8, pages 1237-1246.
Read now

Articles from other publishers (4)

Wenzhan Yang, Shobha N. Bhattachar, Phenil J. Patel, Margaret Landis, Dipal Patel, Darren L. Reid & Marieta Duvnjak Romic. (2021) Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development. Drug Discovery Today 26:3, pages 713-723.
Crossref
Kalle Sigfridsson, Aixiang Xue, Kelly Goodwin, Adrian J. Fretland & Torbjörn Arvidsson. (2019) Sustained release and improved bioavailability in mice after subcutaneous administration of griseofulvin as nano- and microcrystals. International Journal of Pharmaceutics 566, pages 565-572.
Crossref
Kalle Sigfridsson, Urban Skantze, Pia Skantze & Lennart Lindfors. 2018. Early Drug Development. Early Drug Development 333 364 .
Anna-Karin Granath & Kalle Sigfridsson. (2016) Evaluation of preclinical formulations for a poorly water-soluble compound. International Journal of Pharmaceutics 511:1, pages 630-637.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.